BrainsWay announced the formation of a strategic partnership with a mental health clinical treatment provider with an expanding footprint in the Northeast region of the U.S. As a result of this partnership and a series of successive orders, a total of 10 Deep Transcranial Magnetic Stimulation systems will be installed by this provider in 2023, with the potential for additional systems thereafter.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BWAY:
- BrainsWay Forges Strategic Partnership with Treatment Provider in Northeast U.S.
- Brainsway announces expanded availability of Deep TMS technology in Taiwan
- BrainsWay Further Expands Access to Deep TMS™ in Asia Pacific Region
- BrainsWay Reports Second Quarter 2023 Financial Results and Operational Highlights
- Brainsway reports Q2 EPS (5c) vs. (7c) last year